Healthcare & Pharmaceuticals Industry Press Releases

Published on February 2, 2023 - 13:00 GMT

Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference

SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 2, 2023 - 13:00 GMT

Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences

BETHESDA, Md., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug discovery with its proprietary computational discovery platform identifying novel allosteric …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:35 GMT

Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference

IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:30 GMT

Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks | Oncology Day on Thursday, February 9, 2023 at 10:10 a.m. ET. The fireside chat …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:30 GMT

PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™ (Ketamine) for the Treatment of Rett Syndrome

PharmaTher’s 5th FDA orphan drug designation for KETARX™ (ketamine) Phase 2 clinical study results to support proposed Phase 3 development of KETARX™ (ketamine) to treat Rett Syndrome for FDA approval via the 505(b)(2) regulatory pathway TORONTO, Feb. 02, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 2, 2023 - 12:30 GMT

Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

WALTHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., chief executive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:05 GMT

Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable ...

- Suprachoroidal CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders - - 67% of Extension Study Participants Went at Least 6 Months Without Needing Additional Treatment - …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on February 2, 2023 - 12:00 GMT

ONL Therapeutics to Present at 2023 BIO CEO & Investor Conference

ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced today that David Esposito, chief …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that the company will participate in two upcoming …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 00:00 GMT

Medlix Health plans to expand in 2023

Medlix Health Expands to New York, Adding 10 New Positions in the First Half of 2023 NORTH YORK, ONTARIO, CANADA, February 1, 2023 /⁨EINPresswire.com⁩/ -- Medlix Health, a leading Canadian medical supply provider, is proud to announce that it is expanding …

Distribution channels: Beauty & Hair Care, Chemical Industry ...

Published on February 2, 2023 - 12:00 GMT

SweetWater Brewing Company Introduces New Crisp Lager to Year-Round Lineup

ATLANTA, Feb. 02, 2023 (GLOBE NEWSWIRE) -- SweetWater Brewing Company, LLC ("SweetWater"), a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), Atlanta’s craft beer trailblazer and the 10th largest craft brewer in the U.S., launches …

Distribution channels:

Published on February 2, 2023 - 12:00 GMT

Anavex Life Sciences Announces Exceeding of Enrollment Target for the ANAVEX®2-73 (blarcamesine) EXCELLENCE Phase 2/3 Rett ...

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Agios to Webcast Conference Call of Fourth Quarter and Year End 2022 Financial Results on Feb. 23, 2023

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Dentsply Sirona to Host Fourth Quarter and Full Year 2022 Conference Call on February 28th

CHARLOTTE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Tuesday, February 28, 2023, at 8:30 am ET to review …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Tango Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio, Inc.

The Acquired Portfolio of Infectious Disease Assets Includes a Class of Potential Broad Spectrum Oral Antiviral Agents, TNX-3900 with a Host-Directed Mechanism Tonix Plans to Develop the TNX-3900 Series of Molecules as Oral Antivirals Either as Monotherapy …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 ...

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...

Published on February 2, 2023 - 12:00 GMT

First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis

BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 12:00 GMT

Digital Radiography Market Size (2022-2030) Share, Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

Newark, New Castle, USA, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Digital Radiography Market by Product (Computed Radiography, Direct Digital Radiography), by Type (Dynamic, Static), by Application (General, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire